Synapse is going international! A one week international seminar for students and young professionals to visit and network with company representatives in one of Europe’s leading Life Science clusters.
Synapse is going international again, and YOU can be a part of it!
After the successes of 2016, 2017, and 2018 we are happy to announce that Synapse Connect UK 2019 is already in the making. Synapse Connect UK is a week-long international seminar in the United Kingdom during which you will be able to visit the grand life science cluster of London and Cambridge. Through this seminar, you will have the opportunity to learn from world-leading companies the art of transforming an idea to a product in the pharmaceutical industry and how to successfully introduce it to the market. Furthermore, you will discover alternative professional opportunities and network with local students and professionals in a strong international environment that will put Danish students and research back on the map.
More information on the dates and programme for the 2019 seminar will follow - but it will consist of company visits and workshops in collaboration with:
- Biotech companies
- Pharmaceutical industry leaders
- Innovation hubs
- Venture capital firms
- Cluster organizations
- And much more!
And of course, a lot of social activities with the other students as well as networking events with local students and professionals.
We will require:
- a Cover Letter (in English!) of approximately one page explaining why you want to join this event and what you can add to the team we will send to the UK;
- a CV (also in English) of max. 2 pages.
- You need to study in Denmark or Southern Sweden in order to attend this event. Newly graduates that reside in these areas are also welcome to apply.
- The seminar will take place in England from April 28th to May 4th 2019.
- There will be an introductory event in Copenhagen, DK on the 29th of March, for all participants prior to the seminar. Futhermore, there will be a case-day on the 7th of April.
- The group will be made up of 40 life science students (Bachelor, Master and PhD) as well as young professionals from Danish and Southern Swedish universities, of which some Synapse members will be joining as organisers.
- The application period is from December 14th 2018 to January 7th 2019.
- There will be a fee for each participant of DKK2500. This fee will include transportation to and from the UK, housing and transportation required for the seminar. It will also include all breakfasts and some additional meals. Fee is non-refundable.
If you have any questions please email us at firstname.lastname@example.org
Join if you are interested in:
- diving into the process of product development with top strategic companies
- discovering alternative career opportunities outside of academia
- being part of new national and international Life Science networks.
Companies for 2019
We can now reveal some of the confirmed companies for this years Synapse Connect UK seminar. We will both be visiting some of the companies we have had great experiences with the previous years, but there are also some new interesting companies that are part of the one week program this year.
We have are creating a program with a wide spectrum of life science companies. That will all in all give a understanding of what companies in the industry is working towards and an insight into all the opportunities there is within the grand life science cluster of London on Cambridge. Here is a short introduction of some of the confirmed companies.
Phoremost is a new-model drug discovery company based in Cambridge, UK. Using its core expertise to open up new “druggable” target space and working with a global network of co-invested academic and industrial collaboration partners, they aim to bring a wide array of novel ‘targeted’ therapies more efficiently to market and pass these cost savings onto patients.
Mission Therapeutics vision is to transform the treatment of serious diseases by targeting disease-associated deubiquitylating enzymes to harness a new class of drugs. They focus on areas of significant unmet medical need – disease areas where new therapeutics have the potential to make dramatic improvements in the quality of life and survival of patients.
One Nucleus is an award winning not-for-profit Life Sciences and Healthcare membership organisation centred on the Greater London-Cambridge-East of England corridor. Through providing the local, UK-wide and international connectivity, One Nucleus seeks to enable their members to maximise their performance. This support helping them achieve, or better exceed, the goals they have set for themselves.
Lonza is one of the world's leading and most trusted suppliers to the Pharma&Biotech and Specialty Ingredient markets. Lonza’s Applied Protein Services team, located at the Cambridge site, focuses on a full risk assessment platform for in silico and in vitro services for immunogenicity, stability, humanization, and protein engineering. These technologies include the award winning and patented EpibaseTM T cell epitope screening platform along with their proprietary technology platform for structural protein engineering.
Topra is a professional membership organisation for individuals working in healthcare regulatory affairs. They work with their members internationally to enable and promote excellence across the healthcare regulatory profession. Their mission is to represent and promote the profession of healthcare regulatory affairs globally.
Welcome trust exists to improve health by helping great ideas to thrive. They support researchers, take on big health challenges, campaign for better science and help everyone get involved with science and health research. Based on last year’s success, Synapse Connect UK 2019 will feature a case competition in collaboration with Welcome Trust.
Stemnovate’s compliant organs-on-chip platforms integrate stem cell research and tissue engineering to provide physiological alternative to cancer lines and animal models for precision drug discovery and screening. Their platform technology provides an opportunity to execute the vision of high-throughput and cost-effective drug discovery.
SynbiCITE is the Innovation and Knowledge Centre (IKC) for Synthetic Biology, based at Imperial College London. Their prime object is to accelerate and promote the commercial exploitation of synthetic biology research and engineering biology applications. SynbiCITE is a unique collaboration of the UK’s leading academic institutions and industrial partners, ranging from start-ups to large multinational companies.
EBML-EBI(The European Molecular Biology Laboratory – European Bioinformatics Institute) provides the world’s public biological data freely available to the scientific community via a range of services and tools, perform basic research and provide professional training in bioinformatics. They contribute to the advancement of biology through investigator-driven research and help disseminate cutting-edge technologies to the industry.
F-star is a leader in the discovery and development of novel bispecific antibodies. F-star is a biopharmaceutical company focused on developing immune-oncology bispecific antibody therapeutics. They are committed to delivering life-changing treatments to those cancer patients who are not well-served by current therapies through the application of their highly efficient Modular Antibody TechnologyTMplatform.
Pfizer is one of the world’s premier innovative biopharmaceutical companies, discovering, developing and providing over 160 different medicines, vaccines and consumer healthcare products to help improve the lives of millions of people in the UK and around the world every day.
In Spring 2017, the second Synapse Connect UK seminar took place. Once again 40 top Life Science students embarked on a journey to explore the Life Science cluster in London and Cambridge but this time new, exciting names had been added to the list of companies to visit. The focus was maintained on the span from developing an idea into a company to growing that company and eventually working in a large company. The program was spiced up with a visit behind the scenes at Lonza and MedImmune, a bioinformatics workshop at EMBL-EBI and a whole day at the Wellcome Trust Foundation’s headquaters in London. The ties between participants and British students were also strengthened by holding a joint event with the Science Innovation Union – a British student organisation that (like Synapse) aims to close the gap between academia and industry in Life Science.
In Spring 2016, we launched our first Synapse Connect seminar. During Synapse Connect UK ‘16, a large group of ambitious students and young professional were welcomed into the Life Science milieu of one of the most prominent Life Science clusters in Europe, the Cambridge/London area. In 5 intense days of visiting and networking with company professionals, likeminded British students, and each other, participants became familiar with the newest knowledge in the fields of cancer immunotherapy, pharmacological research, alternative job opportunities, recruitment tactics for new graduates, and the legal background of law firms in the Life Sciences. Furthermore, students were invited to attend a Formal Hall dinner in one of the oldest houses of University of Cambridge along with professors and students of their leading entrepreneurial degree, Master of Bioscience Enterprise. Topics covered included everything from how to spin an idea into a company and how venture capital work to the diverse career paths a Life Science student can follow in the big pharma and bioindustry.